KAP vs Ketamine-Assisted EMDR™ (KA-EMDR)
A side-by-side comparison of recorded mechanisms, evidence review status, related condition topics, and philosophical roots.
At a glance
Source checks, condition-specific assessments and expert review are separate steps. Each assessment applies only to its stated population and use. Topic links do not establish comparative effectiveness.
KAP
- Tradition
- Psychedelic
- Founder
- Various (Wolfson, Bennett) (2010)
- Review status
- 7 source checks available
- Official sources
Guidelines and official sources (7)
6 clinical guideline checks · 1 regulatory source check
Read the recommendation and its scope. A source may discuss an approach without recommending it.
- SPRAVATO (esketamine) original prescribing information
Not a treatment recommendation
The historical drug indication is verified. It does not establish approval or guideline endorsement of KAP. This original label is not current prescribing information.
Scope: Esketamine nasal spray plus an oral antidepressant for adult TRD in 2019
- Management of Major Depressive Disorder
Discussed in the source
VA/DoD weakly suggests ketamine or esketamine augmentation. The recommendation concerns medication, not a named KAP psychotherapy protocol.
Scope: MDD after several adequate pharmacological trials have failed
- Clinical Practice Guideline for Management of PTSD and Acute Stress Disorder
Discussed in the source
VA/DoD weakly recommends against ketamine for PTSD. The statement concerns medication and does not separately evaluate KAP.
Scope: Ketamine pharmacotherapy for adult PTSD; not a separate KAP psychotherapy assessment.
- Assessment and Management of Patients at Risk for Suicide
Discussed in the source
VA/DoD weakly supports ketamine infusion for short-term ideation reduction; evidence for preventing attempts or suicide is insufficient. KAP is not separately recommended.
Scope: Adjunctive ketamine infusion in adults aged 18 and over with major depression and suicidal ideation; medication rather than KAP psychotherapy.
- Management of Major Depressive Disorder
Discussed in the source
VA/DoD suggests against ketamine/esketamine as initial pharmacotherapy (weak against). Its separate augmentation recommendation concerns prior treatment failure; neither recommendation endorses a named KAP psychotherapy protocol.
Scope: Adults choosing initial medication treatment for MDD.
- Management of Bipolar Disorder
Discussed in the source
VA/DoD finds insufficient evidence for ketamine/esketamine alone or as adjuncts. The recommendation concerns medication and does not endorse KAP psychotherapy.
Scope: Adults with acute bipolar depression.
- Clinical Practice Guideline for the Treatment of Posttraumatic Stress Disorder in Adults
Discussed in the source
APA reports insufficient evidence for ketamine in these comparisons. This is a drug-level finding, not a separate evaluation of the KAP psychotherapy protocol.
Scope: Adults with PTSD; ketamine compared with an active or inactive intervention.
- SPRAVATO (esketamine) original prescribing information
- Focus
- Experiential + Processing
- Format
- Individual
- Duration
- Short-medium
Ketamine-Assisted EMDR™ (KA-EMDR)
- Tradition
- Integrative
- Founder
- Danielle Ciccone & Michele Topel (2024)
- Review status
- Assessment not yet completed
- Focus
- Somatic + Cognitive
- Format
- Individual
- Duration
- Short to Medium
How they work
KAP
Core mechanism: Ketamine's dissociative state, and the plasticity that follows it, are treated as a window for psychotherapeutic processing and new learning; the window is proposed rather than demonstrated
Ontology: Treatment-resistant conditions involve rigid neural patterns; ketamine disrupts rigidity and opens plasticity window
Ketamine-Assisted EMDR™ (KA-EMDR)
Core mechanism: Standard 8-phase EMDR protocol adapted for ketamine integration. Client self-administers low-dose sublingual ketamine (troches) at a strategically timed point during the reprocessing phases. The psycholytic dose is intended to expand the window of tolerance and enhance neuroplasticity while preserving the client's capacity to engage in bilateral stimulation and verbal processing, unlike higher-dose psychedelic approaches that impair interactive participation.
Ontology: Traumatic memories are stored in maladaptive neural networks (per EMDR's Adaptive Information Processing model). Low-dose ketamine enhances neuroplasticity and the memory reconsolidation window, allowing EMDR's bilateral stimulation to reprocess traumatic material more effectively. The pharmacological and psychotherapeutic mechanisms are proposed as synergistic rather than additive.
Related condition topics
These editorial cross-references organize reading. A shared link does not mean both approaches are effective, recommended, or interchangeable for that condition.
1 shared · 3 KAP-only · 0 Ketamine-Assisted EMDR™ (KA-EMDR)-only
Linked to both entries
Linked only in the KAP entry
What each assumes — and misses
KAP
Philosophical roots: James (varieties of religious experience: altered states as data); Grof (non-ordinary states); Wolfson (ketamine as psychedelic medicine rather than anesthetic adjunct); neuroplasticity research
Blind spots: Regulatory fragmentation; limited standardization of psychotherapy component; risk of ketamine becoming the treatment rather than catalyst
Therapeutic voice: Last week you kept coming back to 'none of it is solid.' Let's stay there. What have you been treating as solid?
Ketamine-Assisted EMDR™ (KA-EMDR)
Philosophical roots: Inherits EMDR's basis in information processing theory and memory reconsolidation science. The ketamine component draws on psycholytic therapy tradition (Passie et al., 2022): the use of sub-psychedelic doses to enhance psychotherapeutic process rather than induce altered states as the primary intervention.
Blind spots: Rests on a single uncontrolled pilot study with no comparator, run by the modality's own developers; requires the client to self-administer a Schedule III dissociative anesthetic mid-session rather than have it clinician-administered; the protocol name is trademarked and taught only through the founders' own institute, the same training-revenue structure flagged elsewhere on this site; combines two modalities, ketamine and EMDR's bilateral stimulation, whose interaction has not been independently studied, so the claimed synergy between pharmacological and psychotherapeutic mechanisms is a hypothesis, not a finding
Therapeutic voice: The dose is low on purpose. You should still be able to talk to me and follow the tapping, and if it gets to be too much we stop the set and stay with the breathing until you're back.
Choosing between them
KAP (Psychedelic) and Ketamine-Assisted EMDR™ (KA-EMDR) (Integrative) come from different traditions, which means they assume different things about what a person is, what causes suffering, and what the therapeutic relationship is for. The choice between them is often less about "which works better" and more about which set of assumptions fits the client and the therapist.
For deeper coverage: see the full KAP and Ketamine-Assisted EMDR™ (KA-EMDR) pages, or use the interactive comparison tool to add more modalities to this comparison.